Insider Selling: Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Director Sells $52,688.05 in Stock

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Rating) Director Blake Borgeson sold 8,885 shares of the firm’s stock in a transaction dated Tuesday, April 18th. The shares were sold at an average price of $5.93, for a total transaction of $52,688.05. Following the transaction, the director now directly owns 7,558,517 shares in the company, valued at […]

Related Keywords

Blake Borgeson ,Recursion Pharmaceuticals Trading ,Needham Company ,News Ratings For Recursion Pharmaceuticals Daily ,Recursion Pharmaceuticals ,Daiwa Securities Group Inc ,Albion Financial Group ,Quarter For Recursion Pharmaceuticals ,Nasdaq ,Recursion Pharmaceuticals Inc ,Baldwin Brothers ,Get Rating ,Director Blake Borgeson ,Wealth Management ,Financial Group ,Securities Group ,Recursion Pharmaceuticals Daily ,Nasdaq Rxrx ,Rxrx ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,